Skip to Content
Merck
  • 2(3H)-benzoxazolone and bioisosters as "privileged scaffold" in the design of pharmacological probes.

2(3H)-benzoxazolone and bioisosters as "privileged scaffold" in the design of pharmacological probes.

Current medicinal chemistry (2005-04-28)
Jacques Poupaert, Pascal Carato, Evelina Colacino, Saïd Yous
ABSTRACT

The 2(3H)-benzoxazolone heterocycle and its bioisosteric surrogates (such as 2(3H)-benzothiazolinone, benzoxazinone, etc.) have received considerable attention from the medicinal chemists owing to their capacity to mimic a phenol or a catechol moiety in a metabolically stable template. These heterocycles and pyrocatechol have indeed similar pKa's, electronic charge distribution, and chemical reactivity. Therapeutic applications of this template are very broad, and range from analgesic anti-inflammatory compounds (including PPAR-gamma antagonists) to antipsychotic and neuroprotective anticonvulsant compounds. High affinity ligands have been obtained also for dopaminergic (D2 and D4), serotoninergic (5-HT1A and 5-HT-2A), sigma-1 and sigma-2 receptors. Owing to the high number of positive hits encountered with this heterocycle and its congeners, 2(3H)-benzoxazolone template certainly deserves the title of "privileged scaffold" in medicinal chemistry.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Pyrocatechol, ≥99%
Sigma-Aldrich
Pyrocatechol, purified by sublimation, ≥99.5%
Sigma-Aldrich
1,2-Dihydroxybenzene, ReagentPlus®, ≥99%